(Q37156709)

18 August 2017

1 reference

title

Management of methicillin-resistant Staphylococcus aureus bacteremia (English)

1 reference

methicillin-resistant Staphylococcus aureus

18 August 2017

main subject

0 references

Staphylococcus aureus

1 reference

2

Vance G Fowler

1 reference

18 August 2017

1

Sara E Cosgrove

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Clinical Infectious Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

46 Suppl 5

1 reference

18 August 2017

page(s)

S386-93

1 reference

Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study

18 August 2017

cites work

1 reference

Staphylococcus aureus endocarditis: a consequence of medical progress

21 January 2018

1 reference

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

Clinical identifiers of complicated Staphylococcus aureus bacteremia

21 January 2018

1 reference

Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters.

21 January 2018

1 reference

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season

21 January 2018

1 reference

Metastatic complications of Staphylococcus aureus septicemia. To seek is to find

21 January 2018

1 reference

Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients

21 January 2018

1 reference

Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark.

21 January 2018

1 reference

Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia

21 January 2018

1 reference

Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.

21 January 2018

1 reference

Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators.

21 January 2018

1 reference

Valve replacement in patients with native valve endocarditis: what really determines operative outcome?

21 January 2018

1 reference

Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death.

21 January 2018

1 reference

Long-term outcome of infective endocarditis: the impact of early surgical intervention.

21 January 2018

1 reference

Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

Fifteen years' experience with staphylococcus septicemia in a large city hospital; analysis of fifty-five cases in the Cincinnati General Hospital 1940 to 1954.

21 January 2018

1 reference

Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review

21 January 2018

1 reference

Practice guidelines for the management of bacterial meningitis

21 January 2018

1 reference

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

21 January 2018

1 reference

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

21 January 2018

1 reference

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

21 January 2018

1 reference

The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia

21 January 2018

1 reference

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

21 January 2018

1 reference

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis.

21 January 2018

1 reference

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

21 January 2018

1 reference

Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers

21 January 2018

1 reference

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

21 January 2018

1 reference

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

21 January 2018

1 reference

Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity

21 January 2018

1 reference

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

21 January 2018

1 reference

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

Occurrence of MRSA endocarditis during linezolid treatment

21 January 2018

1 reference

Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid

21 January 2018

1 reference

Persistent MRSA bacteremia in a patient with low linezolid levels

21 January 2018

1 reference

Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies

21 January 2018

1 reference

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

21 January 2018

1 reference

Arthralgias and myalgias related to quinupristin-dalfopristin administration

21 January 2018

1 reference

Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin

21 January 2018

1 reference

Clinical experience with recently approved antibiotics

21 January 2018

1 reference

Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens

21 January 2018

1 reference

Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria

21 January 2018

1 reference

Telavancin: a novel lipoglycopeptide for serious gram-positive infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/533595

1 reference

18 August 2017

1 reference